DSP Healthcare Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹100

DSP Healthcare Growth Direct Plan

NAV
₹44.4240
-0.65%
(18 Jul)
AUM
3,057 Cr
TER
0.62%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is above its 200 days moving average
Asset Under Management (AUM) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+14.6%
+3.2%
-5.4%
-6.2%
-8.1%
3Y
+27.4%
+35.1%
+37.9%
+38.4%
+35.6%
5Y
+24.7%
+38.2%
+31.9%
+30.3%
+33.2%
ALL
+25.2%
+17.7%
+12.2%
+17.3%
+26.1%
VOL
14.7%
18.1%
20.3%
19.8%
22.5%
TER
0.6%
1.1%
0.8%
0.9%
0.5%
AUM
₹3,057 Cr
₹8,043 Cr
₹5,427 Cr
₹1,439 Cr
₹5,687 Cr
INFO
1.71
0.98
0.60
0.87
1.16
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
DSP Healthcare (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Jun
Top holdings
Cipla Ltd
8.8%
Sun Pharmaceuticals Industries Ltd
8.4%
Cohance Lifesciences Ltd
7.9%
Ipca Laboratories Ltd
7.7%
Gland Pharma Ltd
5.5%
Laurus Labs Ltd
5.3%
Alembic Pharmaceuticals Ltd
4.9%
Apollo Hospitals Enterprise Ltd
4.6%
Globus Medical Inc Class A
4.4%
Sai Life Sciences Ltd
4.3%
Top industry exposure
Healthcare
96.7%
Financial Services
1.6%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹100
Additional lumpsum
₹100
Portfolio turnover
22%
Lock-in period
-
Exit load
• 0.5% for redemption within 30 days
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.
Fund manager(s)
Chirag Dagli

FAQs